Utah Medical Products PE Ratio 2010-2024 | UTMD
Current and historical p/e ratio for Utah Medical Products (UTMD) from 2010 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Utah Medical Products PE ratio as of May 14, 2025 is 14.47.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Utah Medical Products PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-05-14 | 54.37 | 13.76 | |
| 2024-12-31 | 61.14 | $3.95 | 15.48 |
| 2024-09-30 | 66.23 | $4.27 | 15.51 |
| 2024-06-30 | 65.84 | $4.33 | 15.21 |
| 2024-03-31 | 69.76 | $4.50 | 15.50 |
| 2023-12-31 | 82.27 | $4.57 | 18.00 |
| 2023-09-30 | 83.72 | $4.64 | 18.04 |
| 2023-06-30 | 90.41 | $4.74 | 19.07 |
| 2023-03-31 | 91.65 | $4.71 | 19.46 |
| 2022-12-31 | 96.91 | $4.51 | 21.49 |
| 2022-09-30 | 81.98 | $4.39 | 18.68 |
| 2022-06-30 | 82.28 | $4.36 | 18.87 |
| 2022-03-31 | 85.77 | $4.18 | 20.52 |
| 2021-12-31 | 95.13 | $4.05 | 23.49 |
| 2021-09-30 | 86.73 | $3.85 | 22.53 |
| 2021-06-30 | 79.20 | $3.50 | 22.63 |
| 2021-03-31 | 80.37 | $2.92 | 27.52 |
| 2020-12-31 | 78.00 | $2.93 | 26.62 |
| 2020-09-30 | 73.67 | $3.17 | 23.24 |
| 2020-06-30 | 81.45 | $3.36 | 24.24 |
| 2020-03-31 | 86.19 | $3.94 | 21.87 |
| 2019-12-31 | 98.56 | $3.94 | 25.02 |
| 2019-09-30 | 87.31 | $3.68 | 23.73 |
| 2019-06-30 | 86.94 | $4.49 | 19.36 |
| 2019-03-31 | 79.90 | $4.70 | 17.00 |
| 2018-12-31 | 74.98 | $4.95 | 15.15 |
| 2018-09-30 | 84.75 | $3.37 | 25.15 |
| 2018-06-30 | 98.82 | $2.54 | 38.90 |
| 2018-03-31 | 88.45 | $2.43 | 36.40 |
| 2017-12-31 | 72.62 | $2.29 | 31.71 |
| 2017-09-30 | 65.40 | $3.68 | 17.77 |
| 2017-06-30 | 64.15 | $3.49 | 18.38 |
| 2017-03-31 | 54.99 | $3.31 | 16.61 |
| 2016-12-31 | 63.93 | $3.21 | 19.92 |
| 2016-09-30 | 52.35 | $3.34 | 15.67 |
| 2016-06-30 | 54.92 | $3.37 | 16.30 |
| 2016-03-31 | 54.30 | $3.28 | 16.56 |
| 2015-12-31 | 50.61 | $3.14 | 16.12 |
| 2015-09-30 | 46.36 | $3.09 | 15.00 |
| 2015-06-30 | 51.07 | $3.03 | 16.85 |
| 2015-03-31 | 51.03 | $3.01 | 16.95 |
| 2014-12-31 | 50.98 | $3.02 | 16.88 |
| 2014-09-30 | 41.21 | $3.14 | 13.12 |
| 2014-06-30 | 43.26 | $3.07 | 14.09 |
| 2014-03-31 | 48.40 | $3.02 | 16.03 |
| 2013-12-31 | 47.62 | $3.03 | 15.72 |
| 2013-09-30 | 49.27 | $2.72 | 18.11 |
| 2013-06-30 | 44.79 | $2.77 | 16.17 |
| 2013-03-31 | 40.02 | $2.72 | 14.71 |
| 2012-12-31 | 29.43 | $2.75 | 10.70 |
| 2012-09-30 | 27.56 | $2.65 | 10.40 |
| 2012-06-30 | 26.99 | $2.53 | 10.67 |
| 2012-03-31 | 24.86 | $2.42 | 10.27 |
| 2011-12-31 | 21.41 | $2.03 | 10.55 |
| 2011-09-30 | 20.82 | $1.93 | 10.79 |
| 2011-06-30 | 20.45 | $1.74 | 11.75 |
| 2011-03-31 | 22.31 | $1.60 | 13.94 |
| 2010-12-31 | 20.57 | $1.65 | 12.46 |
| 2010-09-30 | 21.64 | $1.66 | 13.04 |
| 2010-06-30 | 18.28 | $1.68 | 10.88 |
| 2010-03-31 | 20.45 | $1.70 | 12.03 |
| 2009-12-31 | 21.15 | $1.72 | 12.29 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.180B | $0.041B |
| Utah Medical Products is in the business of producing cost-effective devices for the healthcare industry which are predominantly proprietary, disposable and for hospital use. The company's success in rapidly producing solutions comes from its proven ability to integrate a number of engineering and technical disciplines in electronics, software, mechanical packaging, instrumentation, optics and materials. The resulting proprietary products represent significant incremental improvementsover existing clinical techniques. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $224.526B | 27.00 |
| Boston Scientific (BSX) | United States | $152.309B | 38.13 |
| Stryker (SYK) | United States | $147.916B | 30.93 |
| EssilorLuxottica (ESLOY) | France | $129.703B | 0.00 |
| Medtronic (MDT) | Ireland | $109.157B | 15.94 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.583B | 0.00 |
| Haleon (HLN) | United Kingdom | $47.109B | 26.80 |
| ResMed (RMD) | United States | $36.312B | 27.27 |
| GE HealthCare Technologies (GEHC) | United States | $33.806B | 16.05 |
| Agilent Technologies (A) | United States | $32.907B | 21.74 |
| Terumo (TRUMY) | Japan | $27.953B | 0.00 |
| Koninklijke Philips (PHG) | Netherlands | $22.765B | 16.36 |
| Insulet (PODD) | United States | $22.130B | 86.87 |
| Zimmer Biomet Holdings (ZBH) | United States | $19.288B | 12.39 |
| Baxter (BAX) | United States | $15.985B | 11.94 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.381B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.030B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.091B | 23.97 |
| Lantheus Holdings (LNTH) | United States | $5.462B | 13.78 |
| Prestige Consumer Healthcare (PBH) | United States | $4.298B | 19.20 |
| Perrigo (PRGO) | Ireland | $3.605B | 9.14 |
| ICU Medical (ICUI) | United States | $3.534B | 26.06 |
| Haemonetics (HAE) | United States | $3.473B | 15.13 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.154B | 26.21 |
| QuidelOrtho (QDEL) | United States | $2.401B | 16.52 |
| GN Store Nord (GNNDY) | Denmark | $2.164B | 17.92 |
| LeMaitre Vascular (LMAT) | United States | $1.882B | 42.06 |
| AtriCure (ATRC) | United States | $1.558B | 0.00 |
| Neogen (NEOG) | United States | $1.409B | 18.03 |
| AdaptHealth (AHCO) | United States | $1.217B | 12.36 |
| Kestra Medical Technologies (KMTS) | United States | $1.179B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.172B | 26.35 |
| BioLife Solutions (BLFS) | United States | $1.097B | 0.00 |
| InMode (INMD) | Israel | $1.038B | 9.50 |
| Phibro Animal Health (PAHC) | United States | $0.996B | 12.75 |
| Evolus (EOLS) | United States | $0.653B | 0.00 |
| CeriBell (CBLL) | United States | $0.600B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.577B | 0.00 |
| Owens & Minor (OMI) | United States | $0.559B | 4.63 |
| Valneva SE (VALN) | France | $0.534B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.524B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.453B | 0.00 |
| Surmodics (SRDX) | United States | $0.398B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.350B | 0.00 |
| SNDL (SNDL) | Canada | $0.347B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.333B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.312B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.309B | 11.36 |
| Aurora Cannabis (ACB) | Canada | $0.290B | 51.60 |
| Sanuwave Health (SNWV) | United States | $0.285B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.272B | 22.97 |
| Canopy Growth (CGC) | Canada | $0.267B | 0.00 |
| Omeros (OMER) | United States | $0.258B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.255B | 0.00 |
| Cerus (CERS) | United States | $0.250B | 0.00 |
| ZimVie (ZIMV) | United States | $0.248B | 11.28 |
| Biote (BTMD) | United States | $0.214B | 6.02 |
| OraSure Technologies (OSUR) | United States | $0.198B | 0.00 |
| High Tide (HITI) | Canada | $0.186B | 0.00 |
| Brainsway (BWAY) | Israel | $0.185B | 49.05 |
| Quanterix (QTRX) | United States | $0.180B | 0.00 |
| Organigram Global (OGI) | Canada | $0.166B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.164B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.148B | 18.19 |
| Jin Medical (ZJYL) | China | $0.133B | 0.00 |
| Exagen (XGN) | United States | $0.120B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.116B | 0.00 |
| Agape ATP (ATPC) | $0.101B | 0.00 | |
| MacroGenics (MGNX) | United States | $0.097B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.092B | 0.00 |
| Fonar (FONR) | United States | $0.077B | 10.71 |
| Veru (VERU) | United States | $0.076B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.072B | 0.00 |
| InterCure (INCR) | Israel | $0.070B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.070B | 0.00 |
| Zynex (ZYXI) | United States | $0.066B | 0.00 |
| United Health Products (UEEC) | United States | $0.061B | 0.00 |
| Apyx Medical (APYX) | United States | $0.060B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.054B | 0.00 |
| ImmuCell (ICCC) | United States | $0.045B | 0.00 |
| Modular Medical (MODD) | United States | $0.040B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.94 |
| Rockwell Medical (RMTI) | United States | $0.037B | 0.00 |
| Safety Shot (SHOT) | United States | $0.034B | 0.00 |
| Nephros (NEPH) | United States | $0.023B | 0.00 |
| INLIF (INLF) | $0.020B | 0.00 | |
| Allurion Technologies (ALUR) | United States | $0.018B | 0.00 |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.011B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |